{
  "id": "5e49a1196d0a27794100000d",
  "type": "yesno",
  "question": "Is PF-05190457 an inverse agonist of the ghrelin receptor?",
  "ideal_answer": "Yes, PF-05190457 is an inverse agonist of the ghrelin receptor.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27621150"
  ],
  "snippets": [
    {
      "text": "Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27621150",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To evaluate safety, tolerability and pharmacokinetics of oral PF-05190457, an oral ghrelin receptor inverse agonist, in healthy adults.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27621150",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " PF-05190457 is a well-tolerated first-in-class ghrelin receptor inverse agonist with acceptable pharmacokinetics for oral daily dosing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27621150",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}